Subcutaneous delivery of methylnaltrexone may circumvent this potential drawback while providing potentially rapid, effective treatment for OIC. Once-daily dosing may also help to minimize ...
Objective: To assess safety and efficacy of subcutaneous methylnaltrexone in patients with acute OIC after orthopedic procedures. Design: Double-blind, randomized, parallel-group, placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback